Summit Healthcare REIT 10Q 2022 Q2 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-52566

SUMMIT HEALTHCARE REIT, INC.

(Exact name of registrant as specified in its charter)


MARYLAND	73-1721791
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

23382 MILL CREEK DRIVE, SUITE 125, LAGUNA HILLS, CA	92653
(Address of principal executive offices)	(Zip Code)

800-978-8136

(Registrant’s telephone number, including area code)

2 SOUTH POINTE DRIVE, SUITE 100, LAKE FOREST, CA 92630

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Ticker symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ⌧ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ⌧ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☒

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ⌧ No

As of August 5, 2022, we had 23,027,978 shares of common stock of Summit Healthcare REIT, Inc. outstanding.

Table of Contents

FORM 10-Q

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

TABLE OF CONTENTS


PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements:	3
	Condensed Consolidated Balance Sheets (unaudited)	3
	Condensed Consolidated Statements of Operations (unaudited)	4
	Condensed Consolidated Statements of Equity (unaudited)	5
	Condensed Consolidated Statements of Cash Flows (unaudited)	6
	Notes to Condensed Consolidated Financial Statements (unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39
Item 4.	Controls and Procedures	40
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	40
Item 3.	Defaults Upon Senior Securities	40
Item 4.	Mine Safety Disclosures	40
Item 5.	Other Information	40
Item 6.	Exhibits	41
SIGNATURES		42

EX-31.1
EX-31.2
EX-32

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)


	June 30,		December 31,
	2022		2021
ASSETS
Cash and cash equivalents	$	13,067,000	$	10,488,000
Restricted cash		2,700,000		2,673,000
Real estate properties, net		176,181,000		179,102,000
Intangible lease assets, net		14,196,000		14,687,000
Tenant and other receivables, net		4,260,000		3,386,000
Deferred leasing commissions, net		418,000		466,000
Other assets, net		1,519,000		422,000
Equity-method investments		7,523,000		7,902,000
Total assets	$	219,864,000	$	219,126,000

LIABILITIES AND EQUITY
Accounts payable and accrued liabilities	$	5,888,000	$	2,551,000
Security deposits		4,650,000		4,651,000
Loans payable, net of debt issuance costs		180,276,000		180,370,000
Total liabilities		190,814,000		187,572,000

Commitments and contingencies
Stockholders’ Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued or outstanding at June 30, 2022 and December 31, 2021		—		—
Common stock, $0.001 par value; 290,000,000 shares authorized; 23,027,978 shares issued and outstanding at June 30, 2022 and December 31, 2021		23,000		23,000
Additional paid-in capital		116,415,000		116,401,000
Accumulated deficit		(87,560,000)		(85,041,000)
Total stockholders’ equity		28,878,000		31,383,000
Noncontrolling interests		172,000		171,000
Total equity		29,050,000		31,554,000
Total liabilities and equity	$	219,864,000	$	219,126,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Revenues:
Total rental revenues	$	5,435,000	$	1,284,000	$	10,976,000	$	2,208,000
Resident fees and services		863,000		—		1,271,000		—
Acquisition and asset management fees		165,000		295,000		330,000		624,000
Interest income from notes receivable		—		4,000		—		13,000
Total operating revenue		6,463,000		1,583,000		12,577,000		2,845,000

Expenses:
Property operating costs		766,000		210,000		1,539,000		430,000
Resident costs		818,000		—		1,193,000		—
General and administrative		1,132,000		862,000		2,180,000		2,493,000
Depreciation and amortization		1,848,000		393,000		3,685,000		792,000
Total operating expenses		4,564,000		1,465,000		8,597,000		3,715,000

Operating income (loss)		1,899,000		118,000		3,980,000		(870,000)

Loss from equity-method investees		(1,131,000)		(550,000)		(489,000)		(785,000)
Gain on sale of equity-method investment		—		3,515,000		—		3,515,000
Other income		161,000		6,000		163,000		11,000
Interest expense		(3,105,000)		(516,000)		(6,136,000)		(1,038,000)
Net (loss) income		(2,176,000)		2,573,000		(2,482,000)		833,000
Noncontrolling interests’ share in net (income) loss		(18,000)		(22,000)		(37,000)		(40,000)
Net (loss) income applicable to common stockholders	$	(2,194,000)	$	2,551,000	$	(2,519,000)	$	793,000

Earnings per common share:
Basic:
(Loss) income	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Net (loss) income applicable to common stockholders	$	(0.10)	$	0.11	$	(0.11)	$	0.03

Diluted:
(Loss) income	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Net (loss) income applicable to common stockholders	$	(0.10)	$	0.11	$	(0.11)	$	0.03

Weighted average shares used to calculate earnings per common share
Basic		23,027,978		23,027,978		23,027,978		23,027,978
Diluted		23,027,978		23,553,606		23,027,978		23,553,606

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(Unaudited)


	Common Stock
		Common
	Number	Stock		Additional				Total
	of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total
	Shares	Value		Capital		Deficit		Equity		Interests		Equity
Balance — January 1, 2022	23,027,978	$	23,000	$	116,401,000	$	(85,041,000)	$	31,383,000	$	171,000	$	31,554,000
Stock-based compensation	0		0		8,000		0		8,000		0		8,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(18,000)		(18,000)
Net (loss) income	0		0		0		(325,000)		(325,000)		19,000		(306,000)
Balance — March 31, 2022	23,027,978	$	23,000	$	116,409,000	$	(85,366,000)	$	31,066,000	$	172,000	$	31,238,000
Stock-based compensation	0		0		6,000		0		6,000		0		6,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(18,000)		(18,000)
Net (loss) income	0		0		0		(2,194,000)		(2,194,000)		18,000		(2,176,000)
Balance — June 30, 2022	23,027,978	$	23,000	$	116,415,000	$	(87,560,000)	$	28,878,000	$	172,000	$	29,050,000


	Common Stock
		Common
	Number	Stock		Additional				Total
	of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total
	Shares	Value		Capital		Deficit		Equity		Interests		Equity
Balance — January 1, 2021	23,027,978	$	23,000	$	116,335,000	$	(84,456,000)	$	31,902,000	$	195,000	$	32,097,000
Stock-based compensation	0		0		36,000		0		36,000		0		36,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(16,000)		(16,000)
Net (loss) income	0		0		0		(1,758,000)		(1,758,000)		18,000		(1,740,000)
Balance — March 31, 2021	23,027,978	$	23,000	$	116,371,000	$	(86,214,000)	$	30,180,000	$	197,000	$	30,377,000
Stock-based compensation	0		0		11,000		0		11,000		0		11,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(19,000)		(19,000)
Net income (loss)	0		0		0		2,551,000		2,551,000		22,000		2,573,000
Balance — June 30, 2021	23,027,978	$	23,000	$	116,382,000	$	(83,663,000)	$	32,742,000	$	200,000	$	32,942,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Six Months Ended June 30,
	2022		2021
Cash flows from operating activities:
Net (loss) income	$	(2,482,000)	$	833,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Amortization of debt issuance costs		457,000		34,000
Depreciation and amortization		3,685,000		792,000
Amortization of above-market lease intangible		32,000		—
Straight-line rents		(748,000)		494,000
Stock-based compensation expense		14,000		47,000
Gain on sale of equity-method investment		—		(3,515,000)
Loss from equity-method investees		489,000		785,000
Change in operating assets and liabilities:
Tenant and other receivables, net		202,000		501,000
Other assets		(261,000)		275,000
Accounts payable and accrued liabilities		2,387,000		83,000
Net cash provided by operating activities		3,775,000		329,000

Cash flows from investing activities:
Additions to real estate		(132,000)		—
Investment in equity-method investees		(722,000)		(123,000)
Proceeds from sale of equity-method investment		—		5,411,000
Distributions received from equity-method investees		272,000		1,250,000
Payments from notes receivable		—		123,000
Net cash (used in) provided by investing activities		(582,000)		6,661,000

Cash flows from financing activities:
Payments of loans payable		(551,000)		(518,000)
Distributions paid to noncontrolling interests		(36,000)		(35,000)
Net cash used in financing activities		(587,000)		(553,000)

Net increase in cash, cash equivalents and restricted cash		2,606,000		6,437,000
Cash, cash equivalents and restricted cash – beginning of period		13,161,000		17,591,000
Cash, cash equivalents and restricted cash – end of period	$	15,767,000	$	24,028,000

Supplemental disclosure of cash flow information:
Cash paid for interest	$	4,809,000	$	816,000

Supplemental disclosure of non-cash investing activities:
Additions to real estate included in accounts payable and accrued liabilities	$	112,000	$	0

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022

(Unaudited)

1. Organization

Summit Healthcare REIT, Inc. (“Summit”) is a real estate investment trust that owns 100% of 14 properties, 95.3% of four properties, a 10% equity interest in an unconsolidated equity-method investment that holds 17 properties, a 35% equity interest in an unconsolidated equity-method investment that holds 1 property, a 20% equity interest in an unconsolidated equity-method investment that holds 2 properties, a 10% equity interest in an unconsolidated equity-method investment that holds 9 properties, a 10% equity interest in an unconsolidated equity-method investment that holds six properties. In June 2021, we sold our 15% equity interest in an unconsolidated equity-method investment that held 14 properties. Summit is a Maryland corporation, formed in 2004 under the General Corporation Law of Maryland for the purpose of investing in and owning real estate. As used in these notes, the “Company”, “we”, “us” and “our” refer to Summit and its consolidated subsidiaries, including but not limited to Summit Healthcare Operating Partnership, L.P. (the “Operating Partnership”), except where the context otherwise requires.

We conduct substantially all of our operations through the Operating Partnership, which is a Delaware limited partnership. We own a 99.88% general partner interest in the Operating Partnership, and Cornerstone Realty Advisors, LLC (“CRA”), a former affiliate, owns a 0.12% limited partnership interest.

Summit and the Operating Partnership are managed and operated as one entity, and Summit has no significant assets other than its investment in the Operating Partnership. Summit, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership. Therefore, the assets and liabilities of Summit and the Operating Partnership are the same.

Cornerstone Healthcare Partners LLC – Consolidated Joint Venture

We own 95% of Cornerstone Healthcare Partners LLC (“CHP LLC”), which was formed in 2012, and the remaining 5% noncontrolling interest is owned by Cornerstone Healthcare Real Estate Fund, Inc. (“CHREF”), an affiliate of CRA. CHP LLC is consolidated within our condensed consolidated financial statements and owns 4 properties (the “JV Properties”) with another partially owned subsidiary. As of June 30, 2022 and December 31, 2021, we own a 95.3% interest in the 4 JV Properties, and CHREF owns a 4.7% interest.

Summit Union Life Holdings, LLC – Equity-Method Investment

In April 2015, through our Operating Partnership, we entered into a limited liability company agreement with Best Years, LLC (“Best Years”), an unrelated entity and a U.S.-based affiliate of Union Life Insurance Co, Ltd. (a Chinese corporation), and formed Summit Union Life Holdings, LLC (the “SUL JV”). The SUL JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, 2022 and December 31, 2021, we have a 10% interest in the SUL JV which owns 17 properties.

Summit Fantasia Holdings, LLC – Equity-Method Investment

In September 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia Investment III LLC (“Fantasia”), an unrelated entity and a U.S.-based affiliate of Fantasia Holdings Group Co., Limited (a Chinese corporation listed on the Stock Exchange of Hong Kong (HKEX)), and formed Summit Fantasia Holdings, LLC (the “Fantasia JV”). The Fantasia JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, 2022 and December 31, 2021, we have a 35% interest in the Fantasia JV which owns 1 property at June 30, 2022 and owned 2 properties at December 31, 2021.

Table of Contents

Summit Fantasia Holdings II, LLC – Equity-Method Investment

In December 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, and formed Summit Fantasia Holdings II, LLC (the “Fantasia II JV”). The Fantasia II JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, 2022 and December 31, 2021, we have a 20% interest in the Fantasia II JV which owns 2 properties.

Summit Fantasia Holdings III, LLC– Equity-Method Investment

In July 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia and formed Summit Fantasia Holdings III, LLC (the “Fantasia III JV”). The Fantasia III JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, 2022 and December 31, 2021, we have a 10% interest in the Fantasia III JV which owns 9 properties.

Summit Fantasy Pearl Holdings, LLC– Equity-Method Investment

In October 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, Atlantis Senior Living 9, LLC, a Delaware limited liability company (“Atlantis”), and Fantasy Pearl LLC, a Delaware limited liability company (“Fantasy”), and formed Summit Fantasy Pearl Holdings, LLC (the “FPH JV”). The FPH JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, 2022 and December 31, 2021, we have a 10% interest in the FPH JV which owns 6 properties.

Indiana JV– Equity-Method Investment

In June 2021, we sold our 15% equity interest in the Indiana joint venture (the “Indiana JV”) for approximately $5.4 million. See Note 5 for further information.

As of June 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV.

Summit Healthcare Asset Management, LLC (TRS)

Summit Healthcare Asset Management, LLC (“SAM TRS”) is our wholly-owned taxable REIT subsidiary (“TRS”). We serve as the manager of the SUL JV, Fantasia JV, Fantasia II JV, Fantasia III JV, and FPH JV, and the Indiana JV prior to the sale of our equity interest on June 11, 2021 (collectively, our “Equity-Method Investments”), and provide management services in exchange for fees and reimbursements. All asset management fees earned by us are paid to SAM TRS and expenses incurred by us, as the manager, are reimbursed from SAM TRS. See Notes 5 and 7 for further information.

2. Summary of Significant Accounting Policies

For more information regarding our significant accounting policies and estimates, please refer to “Summary of Significant Accounting Policies” contained in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022. In addition, refer to our revenue recognition note below related to our resident fees and services.

The accompanying condensed consolidated balance sheet at December 31, 2021 has been derived from the audited consolidated financial statements at that date. We assume that users of these condensed consolidated financial statements have read or have access to the audited December 31, 2021 consolidated financial statements and contained in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 31, 2022 and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context. Accordingly, footnotes and other disclosures which would substantially duplicate those contained in our most recent Annual Report on Form 10-K for the year ended December 31, 2021 have been omitted in this report.

Table of Contents

Principles of Consolidation and Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries, the Operating Partnership and its consolidated companies and are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). All intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial information reflects all adjustments, which are, in the opinion of management, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown on the condensed consolidated statements of cash flows.


	June 30,		December 31,
	2022		2021
Cash and cash equivalents	$	13,067,000	$	10,488,000
Restricted cash		2,700,000		2,673,000
Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows	$	15,767,000	$	13,161,000

Coronavirus (COVID-19)

The extent to which COVID-19 could continue to impact our business, cash flow and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the rate of public acceptance and usage of vaccines and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, resurgences of COVID-19 and, in particular, new and more contagious and/or vaccine resistant variants, actions taken to contain the spread of COVID-19 and how quickly and to what extent normal economic and operating conditions can resume. The fluidity of this situation precludes any prediction as to the ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to our business, operations, financial condition and liquidity, including recording impairments, lease modifications and credit losses in future periods.

Reclassification of Intangible Lease Assets

The following table provides a reconciliation for the reclassification of our intangible lease assets as of December 31, 2021 in our consolidated balance sheets to conform to the presentation as of June 30, 2022:


	As previously reported		Increase (decrease)		As reclassified
Real estate assets, net	$	192,862,000	$	(13,760,000)	$	179,102,000
Intangible lease assets, net	$	—	$	14,687,000	$	14,687,000
Other assets, net	$	1,349,000	$	(927,000)	$	422,000
Total assets	$	219,126,000	$	—	$	219,126,000

The intangible lease assets related to our prior acquisitions in 2021 were reclassified from real estate properties, net and other assets, net into a separate line item as of June 30, 2022. The result of this reclassification did not have any effect on our total assets, liabilities, accumulated deficit, net loss or statements of cash flows.

Table of Contents

Revenue Recognition - Resident Fees and Services

We recognize resident fees and services revenue at the amount that we expect to be entitled to in exchange for providing resident care and services. Resident fees are recognized and billed monthly based on the contracted rate in the resident lease agreements and the reimbursements from Medicaid are based on contracted reimbursement rates. These amounts are paid directly from the residents and/or third-party payors (currently only Medicaid). Revenue is recognized as performance obligations are satisfied. Performance obligations are determined based on the nature of the services provided by us. The majority of resident fees and services is attributable to the portion of the base monthly lease fee in the resident lease agreement. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes the resident fee revenue based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the lease component is the predominant component and the services included under the resident agreements have the same timing and pattern of transfer and are performance obligations that are satisfied over time. Resident services consist of care level services and certain other ancillary services (i.e., housekeeping, laundry, etc.). These services are provided and paid for in addition to the standard fees included in each resident lease (i.e., room and board, standard meals, etc.).

Laws and regulations concerning government programs, including Medicare and Medicaid, are complex and subject to varying interpretation. As a result of investigations by governmental agencies, various healthcare organizations have received requests for information and notices regarding alleged noncompliance with those laws and regulations, which, in some instances, have resulted in organizations entering into significant settlement agreements. Compliance with such laws and regulations may also be subject to future government review and interpretation as well as significant regulatory action, including fines, penalties and potential exclusion from the related programs. There can be no assurance that regulatory authorities will not challenge our compliance with these laws and regulations, and it is not possible to determine the impact (if any) such claims or penalties would have upon us.

Settlements with third-party payors for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and our historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits, reviews and investigation.

3. Investments in Real Estate Properties

As of June 30, 2022 and December 31, 2021, our investments in real estate properties including those held by our consolidated subsidiaries (excluding the 35 properties owned by our unconsolidated Equity-Method Investments) are set forth below:


	June 30,		December 31,
	2022		2021
Land	$	15,565,000	$	15,565,000
Buildings and improvements		166,989,000		166,989,000
Less: accumulated depreciation		(13,694,000)		(11,395,000)
Buildings and improvements, net		153,295,000		155,594,000
Furniture and fixtures		12,381,000		12,137,000
Less: accumulated depreciation		(5,060,000)		(4,194,000)
Furniture and fixtures, net		7,321,000		7,943,000
Real estate properties, net	$	176,181,000	$	179,102,000

For the three months ended June 30, 2022 and 2021, depreciation and amortization expense (excluding intangible lease amortization and leasing commission amortization) was approximately $1.6 million and $0.4 million, respectively. For the six months ended June 30, 2022 and 2021, depreciation expense (excluding intangible lease amortization and leasing commission amortization) was approximately $3.2 million and $0.8 million, respectively.

As of June 30, 2022, our portfolio consisted of 18 real estate properties, 16 of which were 100% leased to the tenants of the related facilities. The other two properties are each 100% leased to an affiliated subsidiary (see below under Pennington Gardens Operations LLC and Sundial Operations LLC).

Table of Contents

During 2021, our tenants for the Pennington Gardens and Sundial Assisted Living facilities experienced a material adverse effect on their operations related to COVID-19 and other operator issues that affected their ability to make their rent payments in 2022 and 2021. As a result, we experienced the following impacts:

Pennington Gardens Operations LLC

In March 2021, under a receivership, we began recording rent payments on a cash basis for our Pennington Gardens facility and wrote off the remaining straight-line rent receivable of $0.4 million. In October 2021, we reached an agreement with the tenant to terminate the lease. We notified the lender and the U.S. Department of Housing and Urban Development (“HUD”) and requested emergency approval to change the operator and terminate the lease.

On February 3, 2022, the current receiver, who was acting as the operator, received the license to be the licensed operator. As such, on February 10, 2022, the tenant’s lease was terminated, and we received $0.2 million from the tenant as part of the settlement agreement which was recorded in total rental revenues in the condensed consolidated statements of operations for the six months ended June 30, 2022. Concurrently, we entered into a new lease agreement with Pennington Gardens Operations LLC, the newly formed operating company for Pennington Gardens, which is a wholly owned subsidiary of SHOP TRS LLC, a recently formed wholly-owned taxable REIT subsidiary of Summit. As such, the operations of Pennington Gardens are consolidated in our financial statements beginning February 11, 2022, and all intercompany transactions have been eliminated. For the three and six months ended June 30, 2022, revenues from Pennington Gardens Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

Sundial Operations LLC

In October 2021, we reached an agreement with the tenant of our Sundial Assisted Living facility in Redding, California to terminate the lease, and we have requested approval from HUD to terminate the lease and install a new licensed operator/manager. Beginning in June 2021, we recorded rent payments on a cash basis and in May 2021, wrote off the remaining straight-line rent receivable of $0.1 million.

On June 6, 2022, the new operator received approval to be the licensed operator of the facility and the previous tenant’s lease was terminated. We received $0.05 million from the tenant as part of the settlement agreement, which was recorded in total rental revenues in the condensed consolidated statements of operations for the three and six months ended June 30, 2022. On June 7, 2022, we entered into a new lease agreement with Sundial Operations LLC, the newly formed operating company for Sundial Assisted Living, which is a wholly owned subsidiary of SHOP TRS LLC. As such, the operations of Sundial Assisted Living will be consolidated in our financial statements as of June 7, 2022. For the three and six months ended June 30, 2022, revenues from Sundial Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

Table of Contents

The following table provides summary information regarding our portfolio (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the $12.75 million loan from Oxford Finance, LLC (“Oxford”) (see Note 4) with Summit Georgia Holdings LLC, our wholly-owned subsidiary) as of June 30, 2022:

Loans

Payable,

Excluding

Debt

Purchase

Issuance

Property

Location

Date Purchased

Type⁽¹⁾

Price

Costs

Sheridan Care Center

Sheridan, OR

August 3, 2012

SNF

4,100,000

4,087,000

Fernhill Care Center

Portland, OR

August 3, 2012

SNF

4,500,000

3,585,000

Friendship Haven Healthcare and Rehabilitation Center

Galveston County, TX

September 14, 2012

SNF

15,000,000

11,434,000

Pacific Health and Rehabilitation Center

Tigard, OR

December 24, 2012

SNF

8,140,000

5,976,000

Brookstone of Aledo

Aledo, IL

July 2, 2013

8,625,000

6,666,000

Sundial Assisted Living⁽²⁾

Redding, CA

December 18, 2013

3,500,000

3,712,000

Pennington Gardens ⁽²⁾

Chandler, AZ

July 17, 2017

AL/MC

13,400,000

10,117,000

Yucaipa Hill Post Acute

Yucaipa, CA

July 2, 2021

SNF

10,715,000

8,014,000

Creekside Post Acute

Yucaipa, CA

July 2, 2021

SNF

4,780,000

3,575,000

University Post Acute

Mentone, CA

July 2, 2021

SNF

4,560,000

3,411,000

Calhoun Health Center

Calhoun, GA

December 30, 2021

SNF

7,670,000

6,549,000

Maple Ridge Health Care Center

Cartersville, GA

December 30, 2021

SNF

13,548,000

11,568,000

Chatsworth Health Care Center

Chatsworth, GA

December 30, 2021

SNF

29,785,000

25,432,000

East Lake Arbor

Decatur, GA

December 30, 2021

SNF

15,640,000

13,354,000

Fairburn Health Care Center

Fairburn, GA

December 30, 2021

SNF

14,644,000

12,503,000

Grandview Health Care Center

Jasper, GA

December 30, 2021

SNF

10,061,000

8,591,000

Rosemont at Stone Mountain

Stone Mountain, GA

December 30, 2021

SNF

23,908,000

20,414,000

Willowwood Nursing Center & Rehab

Flowery Branch, GA

December 30, 2021

SNF

14,744,000

12,589,000

Total:

207,320,000

171,577,000

(1)	SNF is an abbreviation for skilled nursing facility.

AL is an abbreviation for assisted living facility.

MC is an abbreviation for memory care facility.

(2)See above under Pennington Gardens Operations LLC and Sundial Operations LLC.

Future Minimum Lease Payments

The future minimum lease payments to be received under our existing tenant operating leases (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the intercompany leases between our wholly-owned subsidiaries, Summit Chandler LLC, Pennington Gardens Operations LLC, HP Redding LLC and Sundial Operations LLC) as of June 30, 2022, for the period from July 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows:


Years ending
July 1, 2022 to December 31, 2022	$	8,864,000
2023		17,983,000
2024		18,272,000
2025		18,566,000
2026		18,865,000
Thereafter		165,462,000
	$	248,012,000

2022 Acquisitions

None.

Table of Contents

2021 Acquisitions

CA3 Properties

On July 2, 2021, through our wholly-owned subsidiary, we acquired 3 skilled nursing facilities, 2 located in Yucaipa, California and 1 located in Mentone, California (collectively, the “CA3 Properties”), for the purchase price of $20,055,000, which was funded through cash on hand plus the proceeds from the loan described in Note 4. We incurred approximately $80,000 in acquisition costs in connection with these acquisitions. The CA3 Properties are leased to 3 tenants under three separate 15-year triple net leases, each of which has two five-year renewal options.

GA8 Properties

On December 30, 2021, through Summit Georgia Holdings LLC, our wholly-owned subsidiary, we acquired 8 skilled nursing facilities located in Georgia (collectively, the “GA8 Properties”), for the total purchase price of $130,000,000, which was funded through cash on hand plus the proceeds from the loans described in Note 4. The GA8 Properties are leased to eight tenants under eight separate 15-year triple net leases, each of which has two five-year renewal options.

Leasing Commissions

As a self-managed REIT, we have not paid leasing commissions since 2013. Leasing commissions are capitalized at cost and amortized on a straight-line basis over the related lease term. As of June 30, 2022 and December 31, 2021, the unamortized balance of capitalized leasing commissions was approximately $0.4 million and $0.5 million, respectively. Amortization expense for the three months ended June 30, 2022 and 2021 was approximately $31,000 and $18,000, respectively. Amortization expense for the six months ended June 30, 2022 and 2021 was approximately $48,000 and $35,000, respectively.

Table of Contents

4. Loans Payable

As of June 30, 2022 and December 31, 2021, our loans payable consisted of the following:


	June 30, 2022		December 31, 2021
Loans payable to Lument (formerly ORIX Real Estate Capital, LLC) (insured by HUD) in monthly installments of approximately $183,000, including interest, ranging from a fixed rate of 2.79% to 4.2%, due in September 2039 through April 2055, and as of June 30, 2022 and December 31, 2021, collateralized by Sheridan, Fernhill, Pacific Health, Aledo, Sundial and Friendship Haven.	$	35,460,000	$	35,934,000

Loan payable to Capital One Multifamily Finance, LLC (insured by HUD) in monthly installments of approximately $49,000, including interest at a fixed rate of 4.23%, due in September 2053, and collateralized by Pennington Gardens.		10,117,000		10,194,000

Loan payable to CIBC Bank, USA in monthly installments of approximately of $65,000 interest only through July 2022 at LIBOR (with a floor of 1%) plus 4% (5.12% and 5% at June 30, 2022 and December 31, 2021, respectively), due in July 2024, and as of December 31, 2021, collateralized by Yucaipa Hill Post Acute, Creekside Post Acute and University Post Acute.		15,000,000		15,000,000

Loan payable to CIBC Bank, USA in monthly installments of approximately $314,000 (interest only through December 2023) at SOFR plus 3.50% with a SOFR floor of 0.5%, (4.63% and 4% at June 30, 2022 and December 31, 2021, respectively), due in December 2024, and as of June 30, 2022 and December 31, 2021, collateralized by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab.		91,000,000		91,000,000

Loan payable to Oxford Finance, LLC in monthly installments of approximately $207,000 (interest only through maturity), at LIBOR (with a floor of 1%) plus 11% (12.12% and 12% at June 30, 2022 and December 31, 2021, respectively) due in March 2025, collateralized in second position by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab.		20,000,000		20,000,000

Mezzanine Loan payable to Oxford Finance, LLC in monthly installments of approximately $132,000 (interest only through maturity), at LIBOR (with a floor of 1%) plus 11% (12.12% and 12% at June 30, 2022 and December 31, 2021, respectively) due in December 2026, secured by the equity interests of our wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties.		12,750,000		12,750,000
		184,327,000		184,878,000
Less debt issuance costs		(4,051,000)		(4,508,000)
Total loans payable	$	180,276,000	$	180,370,000

As of June 30, 2022, we have total debt obligations of approximately $184.3 million that will mature between 2024 and 2055. See Note 3 for loans payable balance for each property. All of the loans payable have certain financial and non-financial covenants, including ratios and financial statement considerations. As of June 30, 2022, we were in compliance with all of our debt covenants.

During the three months ended June 30, 2022 and 2021, we incurred approximately $2.7 million and $0.5 million of interest expense, respectively (excluding debt issuance costs amortization and interest expense related to the Oxford mezzanine loan as noted below (“Oxford Monthly Fee”), related to our loans payable. During the six months ended June 30, 2022 and 2021, we incurred approximately $5.2 million and $1.0 million, respectively, of interest expense (excluding debt issuance costs and amortization and interest expense related to the Oxford mezzanine loan as noted below (“Oxford Monthly Fee”)) related to our loans payable.

Table of Contents

In connection with our loans payable, we incurred debt issuance costs. As of June 30, 2022 and December 31, 2021, the unamortized balance of the debt issuance costs was approximately $4.1 million and $4.5 million, respectively. These debt issuance costs are being amortized over the life of their respective financing agreements using the straight-line basis which approximates the effective interest rate method. For the three months ended June 30, 2022 and 2021, $228,000 and $16,000, respectively, of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations. For the six months ended June 30, 2022 and 2021, $457,000 and $34,000, respectively, of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations.

During the three months ended June 30, 2022, we incurred approximately $0.2 million of interest expense related to the Oxford Monthly Fee, which is included in interest expense in our condensed consolidated statements of operations. During the six months ended June 30, 2022, we incurred approximately $0.4 million of interest expense related to the Oxford Monthly Fee and is included in interest expense in our condensed consolidated statements of operations.

The principal payments due on the loans payable (excluding debt issuance costs) for the period from July 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows:


	Principal
Years Ending	Amount
July 1, 2022 to December 31, 2022	$	718,000
2023		1,475,000
2024		106,731,000
2025		21,246,000
2026		14,042,000
Thereafter		40,115,000
	$	184,327,000

The following information notes our recent loan activity:

CA3 Properties

On July 2, 2021, in conjunction with the acquisition of the CA3 Properties (see Note 3), we entered into a first priority $15.0 million mortgage loan collateralized by the CA3 Properties with CIBC Bank, USA (“CIBC”). The loan bears interest at the One Month London Interbank Offer Rate (“LIBOR”) (with a floor of 1%) plus 4.00%, or the Secured Overnight Financing Rate (“SOFR”) when LIBOR is discontinued, and matures on July 2, 2024. The loan is interest only for the first year and thereafter requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the CA3 Properties are refinanced through HUD, otherwise we would be required to pay a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date.

GA8 Properties

We acquired our interest in the GA8 Properties subject to a $91 million first priority mortgage loan collateralized by those properties, a $20 million subordinated term loan collateralized by those properties and a $12.75 million mezzanine loan secured by the equity interests of the wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties.

On December 30, 2021, we entered into a loan agreement with CIBC for $91.0 million in principal amount. The loan bears interest at the SOFR plus 3.50% with a SOFR floor of 50 basis points, or the bank’s base rate plus 0.75% (with a minimum of 4.0%), and matures on December 30, 2024. The loan is interest-only for two years and then requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the GA8 Properties are refinanced through HUD, otherwise we would be required to pay an a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior

Table of Contents

to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more of the GA8 Properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date.

On December 30, 2021, we entered into a subordinated term loan agreement with Oxford for $20.0 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on June 30, 2025. The loan is interest only. The entire loan may be prepaid at any time and would be subject at that time to a prepayment premium fee equal to five percent (5%), two percent (2%) and one percent (1%) of the amount repaid if the repayment is made or the loan is accelerated prior to first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively, or no prepayment fee if the GA8 Properties are refinanced through HUD. Additionally, we are required to pay an exit fee of $100,000 if the loan is paid off by December 31, 2024, or $140,000 if the loan is paid off after that date.

On December 30, 2021, we entered into a mezzanine loan agreement with Oxford for $12.75 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on December 30, 2026. The loan is interest-only and requires a monthly fee in the amount of (i) twenty-two percent (22%) of net cash flow attributable to each month or portion thereof during the loan term, and (ii) five percent (5%) of net cash flow attributable to each month or portion thereof during the post-repayment period which is the earlier of (i) the second anniversary of the loan repayment date and (ii) the date upon which Summit no longer owns any direct or indirect interest in any of the properties and all accrued monthly fees, all excess cash fees and all other liabilities then due agent or lenders are indefeasibly paid in full. The entire Oxford mezzanine loan may be prepaid at any time prior to the three-year anniversary and would be subject at that time to a yield maintenance premium fee equal to the interest that would have been paid for the full three years, which will be due and payable upon the earliest of the maturity or acceleration of the loan, or payment of the loan in full.

HUD-insured loans

We have six properties with HUD-insured loans from Lument Capital (formerly ORIX Real Estate Capital, LLC) and one property with a HUD-insured loan from Capital One Multifamily Finance, LLC. See table above listing loans payable for further information.

All of the HUD-insured loans are subject to customary representations, warranties and ongoing covenants and agreements with respect to the operation of the facilities, including the provision for certain maintenance and other reserve accounts for property tax, insurance, and capital expenditures, with respect to the facilities all as described in the HUD agreements. These reserves are included in restricted cash in our consolidated balance sheets.

5. Equity-Method Investments

As of June 30, 2022 and December 31, 2021, the balances of our Equity-Method Investments were approximately $7.5 million and $7.9 million, respectively, and are as follows:

Summit Union Life Holdings, LLC

The SUL JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the SUL JV (the “SUL LLC Agreement”).

Under the SUL LLC Agreement, net operating cash flow of the SUL JV is distributed monthly, first to the Operating Partnership and Best Years pari passu up to a 9% to 10% annual return, as defined, and thereafter to Best Years 75% and the Operating Partnership 25%. All capital proceeds from the sale of the properties held by the SUL JV, a refinancing or another capital event will be paid first to the Operating Partnership and Best Years pari passu until each has received an amount equal to its accrued but unpaid 9% to 10% return plus its total contribution, and thereafter to Best Years 75% and the Operating Partnership 25%.

For the six months ended June 30, 2022, we invested approximately $650,000 related to a capital call for the SUL JV.

As of June 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the SUL JV was approximately $3.3 million and $2.9 million, respectively.

Table of Contents

Summit Fantasia Holdings, LLC

The Fantasia JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia JV (the “Fantasia LLC Agreement”).

Under the Fantasia LLC Agreement, net operating cash flow of the Fantasia JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 8% return, and thereafter 50% to Fantasia and 50% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 8% return plus its total capital contribution, and thereafter 50% to Fantasia and 50% to the Operating Partnership.

For the six months ended June 30, 2022, we invested approximately $72,000 related to a capital call for the Fantasia JV. In June 2022, the Fantasia JV recorded an impairment charge of approximately $3.2 million and we recorded our 35% share of the impairment of approximately $1.1 million in loss from equity-method investees in the condensed consolidated statements of operations for the three and six months ended June 30, 2022. Additionally, we determined the fair value of our investment in the Fantasia JV to be impaired and recorded a $0.1 million impairment charge which is recorded in the loss from equity-method investees in the condensed consolidated statements of operations for the three and six months ended June 30, 2022.

As of June 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia JV was approximately $1.1 million and $2.0 million, respectively.

Summit Fantasia Holdings II, LLC

The Fantasia II JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia II JV (the “Fantasia II LLC Agreement”).

Under the Fantasia II LLC Agreement, net operating cash flow of the Fantasia JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 8% return, and thereafter 70% to Fantasia and 30% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia II JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 8% return plus its total capital contribution, and thereafter 70% to Fantasia and 30% to the Operating Partnership.

As of June 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia II JV was approximately $1.3 million and $1.3 million, respectively.

Summit Fantasia Holdings III, LLC

The Fantasia III JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia III JV (the “Fantasia III LLC Agreement”).

Under the Fantasia III LLC Agreement, net operating cash flow of the Fantasia III JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 9% return, and thereafter 75% to Fantasia and 25% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia III JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 9% return plus its total capital contribution, and thereafter 75% to Fantasia and 25% to the Operating Partnership.

As of June 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia III JV was approximately $1.5 million and $1.5 million, respectively.

Table of Contents

Summit Fantasy Pearl Holdings, LLC

The FPH JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the FPH JV (the “FPH LLC Agreement”).

Under the FPH LLC Agreement, net operating cash flow of the FPH JV is distributed quarterly, first to the members pari passu until each member has received an amount equal to its accrued, but unpaid 9% return, and thereafter 65.25% to Fantasy, 7.5% to Atlantis, 7.25% to Fantasia and 20% to the Operating Partnership. All capital proceeds from the sale of the properties held by the FPH JV, a refinancing or another capital event, will be paid to the members pari passu until each has received an amount equal to its accrued but unpaid 9% return plus its total capital contribution, and thereafter 65.25% to Fantasy, 7.5% to Atlantis, 7.25% to Fantasia, and 20% to the Operating Partnership.

As of June 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the FPH JV was approximately $0.3 million and $0.2 million, respectively.

Indiana JV

In June 2021, we sold our 15% interest in the Indiana JV for approximately $5.4 million in cash. As of June 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV.

Summarized Financial Data for Equity-Method Investments

Our Equity-Method Investments are significant equity-method investments in the aggregate.

The results of operations of our Equity-Method Investments for the three months ended June 30, 2022 are summarized below:


			Fantasia		Fantasia		Fantasia		FPH		Combined
	SUL JV		JV		II JV		III JV		JV		Total
Revenue	$	5,240,000	$	617,000	$	716,000	$	2,065,000	$	898,000	$	9,536,000
Income (loss) from operations	$	1,469,000	$	(3,499,000)	$	507,000	$	1,017,000	$	413,000	$	(93,000)
Net income (loss)	$	179,000	$	(3,548,000)	$	276,000	$	501,000	$	530,000	$	(2,062,000)
Summit interest in Equity-Method Investments net income (loss)	$	18,000	$	(1,242,000)	$	55,000	$	50,000	$	53,000	$	(1,066,000)	⁽¹⁾

(1)	Included in the loss from equity-method investees in the condensed consolidated statements of operations is an additional $65,000 of impairment related to the Fantasia JV Equity-Method Investment.

The results of operations of our Equity-Method Investments for the three months ended June 30, 2021 are summarized below:


			Fantasia		Fantasia		Fantasia		FPH		Indiana			Combined
	SUL JV		JV		II JV		III JV		JV		JV			Total
Revenue	$	5,091,000	$	951,000	$	921,000	$	2,057,000	$	893,000	$	(2,594,000)	⁽¹⁾	$	7,319,000
Income (loss) from operations	$	1,810,000	$	72,000	$	479,000	$	1,020,000	$	412,000	$	(3,447,000)		$	346,000
Net income (loss)	$	609,000	$	82,000	$	243,000	$	492,000	$	81,000	$	(4,969,000)		$	(3,462,000)
Summit interest in Equity-Method Investments net income (loss)	$	61,000	$	29,000	$	49,000	$	49,000	$	8,000	$	(746,000)		$	(550,000)

(1)	This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $0.6 million in above-market lease amortization and $0.2 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision.

The results of operations of our Equity-Method Investments for the six months ended June 30, 2022 are summarized below:

Table of Contents


			Fantasia		Fantasia		Fantasia		FPH		Combined
	SUL JV		JV		II JV		III JV		JV		Total
Revenue	$	10,435,000	$	1,344,000	$	1,431,000	$	4,130,000	$	1,796,000	$	19,136,000
Income (loss) from operations	$	3,067,000	$	(2,328,000)	$	998,000	$	1,988,000	$	833,000	$	4,558,000
Net income (loss)	$	626,000	$	(2,472,000)	$	536,000	$	978,000	$	1,741,000	$	1,409,000
Summit interest in Equity-Method Investments net income (loss)	$	63,000	$	(866,000)	$	107,000	$	98,000	$	174,000	$	(424,000)	⁽¹⁾

(1)	Included in the loss from equity-method investees in the condensed consolidated statements of operations is an additional $65,000 of impairment related to the Fantasia JV Equity-Method Investment.

The results of operations of our Equity-Method Investments for the six months ended June 30, 2021 are summarized below:


			Fantasia		Fantasia		Fantasia		FPH					Combined
	SUL JV		JV		II JV		III JV		JV		Indiana JV			Total
Revenue	$	10,267,000	$	1,881,000	$	1,841,000	$	4,113,000	$	1,783,000	$	(3,166,000)	⁽¹⁾	$	16,719,000
Income (loss) from operations	$	3,357,000	$	143,000	$	964,000	$	2,057,000	$	833,000	$	(5,093,000)		$	2,261,000
Net income (loss)	$	787,000	$	369,000	$	492,000	$	1,007,000	$	928,000	$	(8,567,000)		$	(4,984,000)
Summit interest in Equity-Method Investments net income (loss)	$	79,000	$	129,000	$	98,000	$	102,000	$	93,000	$	(1,286,000)		$	(785,000)

(1)	This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $1.5 million in above-market lease amortization and $0.4 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision.

Distributions from Equity-Method Investments

As of June 30, 2022 and December 31, 2021, we have distributions receivable, which are included in tenant and other receivables in our condensed consolidated balance sheets, as follows:


	June 30,		December 31,
	2022		2021
SUL JV	$	272,000	$	273,000
Fantasia JV		235,000		205,000
Fantasia II JV		56,000		54,000
Fantasia III JV		33,000		22,000
FPH JV		51,000		28,000
Total	$	647,000	$	582,000

For the six months ended June 30, 2022 and 2021, we have received cash distributions, which are included in our cash flows from operating activities in tenant and other receivables, and cash flows from investing activities, as follows:


	Six Months Ended June 30, 2022						Six Months Ended June 30, 2021
			Cash Flow		Cash Flow				Cash Flow		Cash Flow
	Total Cash		from		from		Total Cash		from		from
	Distributions		Operating		Investing		Distributions		Operating		Investing
	Received		Activities		Activities		Received		Activities		Activities
SUL JV	$	286,000	$	63,000	$	223,000	$	484,000	$	79,000	$	405,000
Fantasia JV		0		0		0		0		0		0
Fantasia II JV		156,000		107,000		49,000		148,000		98,000		50,000
Fantasia III JV		48,000		48,000		—		123,000		101,000		22,000
FPH JV		56,000		56,000		0		77,000		77,000		0
Indiana JV		—		—		—		773,000		0		773,000
Total	$	546,000	$	274,000	$	272,000	$	1,605,000	$	355,000	$	1,250,000

Table of Contents

Asset Management Fees

We serve as the manager of our Equity-Method Investments and provide management services in exchange for fees and reimbursements. As the manager, we are paid an annual asset management fee for managing the properties held by our Equity-Method Investments, as defined in those agreements. For the three months ended June 30, 2022 and 2021, we recorded approximately $0.2 million and $0.3 million, respectively, in asset management fees from our Equity-Method Investments. For the six months ended June 30, 2022 and 2021, we recorded approximately $0.3 million and $0.6 million, respectively, in asset management fees from our Equity-Method Investments (see Note 7).

6. Receivables

Tenant and Other Receivables, Net

Tenant and other receivables, net consists of:


	June 30,		December 31,
	2022		2021
Straight-line rent receivables	$	3,143,000	$	2,395,000
Distribution receivables from Equity-Method Investments		647,000		582,000
Asset management fees		249,000		323,000
Other receivables		221,000		86,000
Total	$	4,260,000	$	3,386,000

7. Related Party Transactions

Equity-Method Investments

See Notes 5 and 6 for further discussion of distributions and asset management fees related to our Equity-Method Investments.

8. Intangible Lease Assets

Intangible lease assets as of June 30, 2022 and December 31, 2021 are as follows:


	June 30,		December 31,
	2022		2021
In-place leases	$	13,778,000	$	13,778,000
Less: accumulated amortization		(477,000)		(18,000)
In-place leases, net		13,301,000		13,760,000
Above-market leases		959,000		959,000
Less: accumulated amortization		(64,000)		(32,000)
Above-market leases, net		895,000		927,000
Total intangible lease assets, net	$	14,196,000	$	14,687,000

For the three months ended June 30, 2022 and 2021, amortization expense for intangible lease assets was approximately $0.2 million and $0, respectively, of which approximately $16,000 and $0, respectively, relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations. For the six months ended June 30, 2022 and 2021, amortization expense for intangible lease assets was approximately $0.5 million and $0, respectively, of which approximately $32,000 and $0, respectively, relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations.

Table of Contents

Expected future amortization of the intangible lease assets as of June 30, 2022, for the period from July 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows:


Years ending December 31,
July 1, 2022 to December 31, 2022	$	490,000
2023		980,000
2024		980,000
2025		980,000
2026		980,000
Thereafter		9,786,000
	$	14,196,000

9. Right of Use (ROU) Asset - Operating

On April 1, 2022, we entered into a temporary space license agreement (“Temporary License”) and a standard office lease (“New Lease”) with Lakehills CM-CG LLC (collectively, the “LH Lease”).

The Temporary License, for space located in Laguna Hills, California, began on April 22, 2022 and expires on the date we move out of such temporary office space or five (5) days after the substantial completion of certain tenant improvements in the office space subject to the New Lease, but in no event later than April 21, 2023. We are entitled to use such office space at no cost during the term of the Temporary License.

Concurrent with the execution of the Temporary License, we entered into the New Lease which begins on or about November 1, 2022 for a period of sixty-six (66) months, with a five-year renewal option. The office space subject to the New Lease is also located in Laguna Hills, California. The New Lease provides for the abatement of the base rent for the second full calendar month through the seventh full calendar month of the lease term. The initial annual base rent is $204,399 and increases three percent (3%) each year on the anniversary date of the commencement of the New Lease.

The LH Lease is classified as an operating lease. An ROU asset represents the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The LH Lease did not provide an explicit rate of interest; therefore we used an estimated incremental borrowing rate of 5% based on a fully collateralized and fully amortizing loan with a maturity date of the same length as the lease that is based on information available at the commencement date in determining the present value of lease payments. At inception, we recorded an ROU asset and lease liability of approximately $888,000. As a result, the Company had non-cash activity of $888,000 for the ROU asset obtained in exchange for new operating lease liabilities. The LH Lease does not contain material residual value guarantees or material restrictive covenants.

Supplemental balance sheet information related to the LH Lease as of June 30, 2022 is as follows:


Component	Consolidated Balance Sheet Caption
Right of use asset - operating	Other assets, net	$	875,000
Lease liability - operating	Accounts payable and accrued liabilities	$	896,000

Lease expense is presented as part of continuing operations within general and administrative expenses in the condensed consolidated statements of operations. For the three and six months ended June 30, 2022, we recognized approximately $20,000 in lease expense and we were not required to make any rent payments. The lease payments will be classified within operating activities in the consolidated statements of cash flows. As of June 30, 2022, we had not made any lease payments and the weighted average remaining lease term is 5.8 years.

Table of Contents

Pursuant to ASC 842, lease payments on the LH Lease for the period from July 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows:


Year	Lease payments
July 1, 2022 to December 31, 2022	$	17,000
2023		120,000
2024		212,000
2025		218,000
2026		224,000
Thereafter		310,000
Total lease payments	$	1,101,000
Less imputed interest ($166,000) and moving expense reimbursement ($39,000)		(205,000)
Total lease liability	$	896,000

10. Concentration of Risk

Our cash is generally invested in short-term money market instruments. As of June 30, 2022, we had cash and cash equivalent accounts in excess of FDIC-insured limits. However, we do not believe the risk associated with this excess is significant.

As of June 30, 2022, we owned 8 properties in Georgia, 4 properties in California, 3 properties in Oregon, 1 property in Texas, 1 property in Illinois, and 1 property in Arizona (excluding the 35 properties held by our Equity-Method Investments). Accordingly, there is a geographic concentration of risk subject to economic conditions in certain states.

Additionally, for the three months ended June 30, 2022, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and 3 of the 14 tenants each represented more than 10% of our rental revenue. For the three months ended June 30, 2021, we leased our 7 real estate properties to 5 different tenants under long-term triple net leases, and 3 of the five tenants each represented more than 10% of our rental revenue.

For the six months ended June 30, 2022, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and 3 of the 14 tenants each represented more than 10% of our rental revenue. For the six months ended June 30, 2021, we leased our 7 real estate properties to 5 different tenants under long-term triple net leases, and 3 of the five tenants each represented more than 10% of our rental revenue.

As of June 30, 2022, our GA8 Properties are considered to be a significant asset concentration as the aggregate net assets of the GA8 Properties were greater than 20% of our total assets due to cross-default provisions in the leases.

11. Fair Value Measurements of Financial Instruments

Our condensed consolidated balance sheets include the following financial instruments: cash and cash equivalents, restricted cash, tenant and other receivables, certain other assets, accounts payable and accrued liabilities, security deposits and loans payable. With the exception of the HUD-insured loans payable discussed below, we consider the carrying values to approximate fair value for such financial instruments because of the short period of time between origination of the instruments and their expected payment and for our Oxford and CIBC loans (per Note 4), the carrying amount approximates fair value because the borrowings are based on variable market interest rates.

As of June 30, 2022 and December 31, 2021, the fair value of our HUD-insured loans payable was $42.9 million and $52.5 million, compared to the principal balance (excluding debt discount) of $45.6 million and $46.1 million, respectively. The fair value of loans payable was estimated using lending rates available to us for financial instruments with similar terms and maturities. To estimate fair value as of June 30, 2022, we used cash flow analyses, based on current interest rates for similar types of borrowing arrangements. As the inputs to our valuation estimate are neither observable in nor supported by market activity, our loans payable are classified as Level 3 liability within the fair value hierarchy.

As a result of our ongoing analysis for potential impairment of our investments in real estate, we may be required to adjust the carrying value of certain assets to their estimated fair values, or estimated fair value less selling costs, under certain circumstances. NaN impairments were recorded during the three and six months ended June 30, 2022 and 2021.

Table of Contents

At June 30, 2022 and December 31, 2021, we do not have any financial assets or financial liabilities that are measured at fair value on a recurring basis in our condensed consolidated financial statements.

12. Commitments and Contingencies

We inspect our properties under a Phase I assessment for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liability with respect to the properties that would have a material effect on our consolidated financial condition, results of operations and cash flows. Further, we are not aware of any environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a loss contingency.

Our commitments and contingencies include the usual obligations of real estate owners and licensed operators in the normal course of business. In the opinion of management, these matters are not expected to have a material impact on our consolidated financial condition, results of operations and cash flows. We are also subject to contingent losses resulting from litigation against the Company.

Legal Proceedings

In September 2015, a bankruptcy petition was filed against Healthcare Real Estate Partners, LLC (“HCRE”) by the investors in Healthcare Real Estate Fund, LLC and Healthcare Real Estate Qualified Purchasers Fund, LLC (collectively, the “Funds”). HCRE did not timely respond to the involuntary petition and the Bankruptcy Court entered an Order of Relief making HCRE a debtor in bankruptcy. As a result, HCRE was removed as manager under the Funds’ operating agreement. Thereafter the Company became the manager of the Funds and purchased the investors’ interests in the Funds for approximately $0.9 million. Following the subsequent dismissal of the involuntary bankruptcy petition filed against it, HCRE filed a motion for attorneys’ fees and damages and a separate complaint for violation of the automatic stay against the petitioning creditors and the Company in the United States Bankruptcy Court of the District of Delaware. The Bankruptcy Court granted a motion to dismiss the complaint for violation of the automatic stay filed jointly by the petitioning creditors and us, and dismissed the complaint with prejudice. HCRE appealed the Bankruptcy Court’s decision to the United States District Court for the District of Delaware which affirmed the Bankruptcy Court’s dismissal of the complaint in a decision dated September 9, 2018. On October 11, 2018, HCRE appealed the District Court’s decision affirming the Bankruptcy Court’s dismissal of the complaint to the United States Court of Appeals for the Third Circuit. On October 22, 2019, the Third Circuit granted HCRE’s appeal, reversing the District Court and holding that HCRE could assert the adversary complaint seeking damages for violation of the automatic stay. The Company filed a Petition for Rehearing on November 5, 2019 asserting that HCRE is not entitled to assert a claim for damages for violation of the automatic stay. This Petition was denied and the mandate was issued sending the matter back to the Bankruptcy Court. The Bankruptcy Court held a status conference on February 4, 2021, and subsequently entered scheduling orders to govern discovery and pretrial matters, and discovery is ongoing. The parties have filed dispositive motions, including a motion filed by the Company and the petitioning creditors for judgment on the pleadings. On February 4, 2022, the Bankruptcy Court entered an order denying the motion for judgment on the pleadings on the basis that the Bankruptcy Court would consider the points raised therein after trial. The Bankruptcy Court also entered an order denying HCRE’s motion to dismiss certain counterclaims and severing certain other counterclaims asserted by the petitioning creditors and the Company against HCRE on jurisdictional grounds, with the effect that such counterclaims may be pursued in the United States District Court. The Bankruptcy Court subsequently entered a further amended scheduling order, directing that remaining discovery be completed by May 15, 2022, which is still ongoing. Based on the assessment by management, the Company believes that a loss is currently not probable or estimable under ASC 450, “Contingencies”, and as of June 30, 2022 and December 31, 2021 no accrual has been made with regard to the claim.

Table of Contents

Indemnification and Employment Agreements

We have entered into indemnification agreements with certain of our executive officers and directors which indemnify them against all judgments, penalties, fines and amounts paid in settlement and all expenses actually and reasonably incurred by him or her in connection with any proceeding. Additionally, effective October 19, 2021, we entered into new employment agreements with our executive officers for a term of three years. These employment agreements include customary terms relating to salary, bonus, position, duties and benefits (including eligibility for equity compensation), as well as a cash payment following a change in control of the Company, as defined in such agreements.

Management of our Equity-Method Investments

As the manager of our Equity-Method Investments, we are responsible for the day-to-day management. Additionally, we could be subject to a capital call from our Equity-Method Investments.

13. Equity

Share-Based Compensation Plans

Upon the grant of stock options, we determine the exercise price by using our estimated per-share value, which is calculated by aggregating the estimated fair value of our investments in real estate and the estimated fair value of our other assets, subtracting the book value of our liabilities, utilizing a discount for the fact that the shares are not currently traded on a national securities exchange and a lack of a control premium, and divided by the total by the number of our common shares outstanding at the time the options were granted.

The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model. Assumptions required by the model include the risk-free interest rate, the expected life of the options, the expected stock price volatility over the expected life of the options, and the expected distribution yield. Compensation expense for employee stock options is recognized ratably over the vesting term. The expected life of the options was based on the simplified method as we do not have sufficient historical exercise data. The risk-free interest rate was based on the U.S. Treasury yield curve at the date of grant with maturity dates approximating the expected term of the options at the date of grant. Volatility was based on historical volatility of the stock prices for a sample of publicly traded companies with risk profiles similar to ours. The valuation model applied in this calculation utilizes highly subjective assumptions that could potentially change over time, including the expected stock price volatility and the expected life of an option.

On April 1, 2022, we granted 81,000 stock options to our non-executive employees under our Summit Healthcare REIT, Inc. 2015 Omnibus Incentive Plan (“Incentive Plan”). The stock options vest monthly beginning on May 1, 2022 and continuing over a three-year period through April 1, 2025. The options expire 10 years from the grant date. The weighted-average fair value per share of the stock options granted was $0.91.

The estimated fair value using the Black-Scholes option-pricing model with the following weighted average assumptions:


	2022
Stock options granted		81,000
Expected volatility		36.5	%
Expected term		5.75	years
Risk-free interest rate		2.53	%
Dividend yield		0	%
Fair value per share	$	0.91

Table of Contents

The following table summarizes our stock options as of June 30, 2022:


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
		Exercise		Contractual	Intrinsic
	Options	Price		Term	Value
Options outstanding at January 1, 2022	1,867,908	$	2.09
Granted	81,000		2.35
Exercised	0
Cancelled/forfeited	—
Options outstanding at June 30, 2022	1,948,908	$	2.10	5.50	$	1,644,000

Options exercisable at June 30, 2022	1,864,046	$	2.09	5.31	$	1,593,000

For our outstanding non-vested options as of June 30, 2022, the weighted average grant date fair value per share was $0.88. As of June 30, 2022, we have unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized as follows:


Years Ending December 31,
July 1, 2022 to December 31, 2022	$	16,000
2023		25,000
2024		25,000
2025		8,000
	$	74,000

The stock-based compensation expense reported for the three months ended June 30, 2022 and 2021 was approximately $6,000 and $11,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations. The stock-based compensation expense reported for the six months ended June 30, 2022 and 2021 was approximately $14,000 and $47,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations.

Table of Contents

14. Earnings Per Share

The following table presents the calculation of basic and diluted earnings per share (“EPS”) for the Company’s common stock for the three and six months ended June 30, 2022 and 2021, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Numerator:
(Loss) income	$	(2,176,000)	$	2,573,000	$	(2,482,000)	$	833,000
(Income) loss attributable to noncontrolling interest		(18,000)		(22,000)		(37,000)		(40,000)
Net (loss) income applicable to common stockholders	$	(2,194,000)	$	2,551,000	$	(2,519,000)	$	793,000

Denominator:
Basic:
Denominator for basic EPS - weighted average shares		23,027,978		23,027,978		23,027,978		23,027,978
Effect of dilutive shares:
Stock options		—		525,628		—		525,628

Denominator for diluted EPS – adjusted weighted average shares		23,027,978		23,553,606		23,027,978		23,553,606

Basic EPS	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Diluted EPS	$	(0.10)	$	0.11	$	(0.11)	$	0.03

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto contained elsewhere in this report. This section contains forward-looking statements, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to numerous risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Forward-looking statements that were true at the time made may ultimately prove to be incorrect or false. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements should be read in light of the risks identified in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2022.

Overview

As of June 30, 2022, our ownership interests in our 18 real estate properties of senior housing facilities was as follows: 100% ownership of 14 properties and a 95.3% interest in four properties in a consolidated joint venture, Cornerstone Healthcare Partners LLC. Additionally, we have a 10% interest in an unconsolidated equity-method investment that owns 17 properties, a 35% equity interest in an unconsolidated equity-method investment that holds one property, a 20% equity interest in an unconsolidated equity-method investment that holds two properties, a 10% equity interest in an unconsolidated equity-method investment that holds nine properties, and a 10% equity interest in an unconsolidated equity-method investment that holds six properties. (collectively, our “Equity-Method Investments”). As used in this report, the “Company,” “we,” “us” and “our” refer to Summit Healthcare REIT, Inc. and its consolidated subsidiaries, except where the context otherwise requires.

Our revenues are comprised largely of tenant rental income from our 18 real estate properties, including rents reported on a straight-line basis over the initial term of each tenant lease, resident fees and services, and asset management fees resulting from our Equity-Method Investments. We also receive cash distributions from our Equity-Method Investments, which are included in net cash provided by operating activities and net cash provided by investing activities in our condensed consolidated statements of cash flows. Our growth depends, in part, on our ability to continue to raise joint venture equity or other equity, acquire new healthcare properties at attractive prices, negotiate long-term tenant leases with sustainable rental rate escalation terms and control our expenses. Our operations are impacted by property-specific, market-specific, general economic, regulatory and other conditions.

We believe that continued investing in senior housing facilities is accretive to earnings and stockholder value. Senior housing facilities include independent living facilities (“IL”), skilled nursing facilities (“SNF”), assisted living facilities (“AL”), memory care facilities (“MC”) and continuing care retirement communities (“CCRC”). Each of these types of facilities focuses on different segments of the senior population.

Coronavirus (COVID-19)

The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. Two of our tenants have experienced a material adverse effect on their operations related to COVID-19, and that has affected their ability to make rent payments in 2022 and 2021 (see Note 3 to the accompanying Notes to Condensed Consolidated Financial Statements for further information on its impact to us). The extent to which COVID-19 could continue to impact our business, cash flow and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the rate of public acceptance and usage of vaccines and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, resurgences of COVID-19 and, in particular, new and more contagious and/or vaccine resistant variants, actions taken to contain the spread of COVID-19 and how quickly and to what extent normal economic and operating conditions can resume.

Summit Portfolio Properties

On July 2, 2021, we acquired three properties in California (the “CA3 Properties”) for approximately $20.1 million. See Notes 3 and 4 to the accompanying Notes to Condensed Consolidated Financial Statements for further information regarding the purchase price and associated financing arrangements.

Table of Contents

On December 30, 2021, we acquired eight properties in Georgia (the “GA8 Properties”) for approximately $130.0 million. See Notes 3 and 4 to the accompanying Notes to Condensed Consolidated Financial Statements for further information regarding the purchase price and associated financing arrangements.

The following table provides summary information (excluding the 35 properties held by our unconsolidated Equity-Method Investments) regarding these properties as of June 30, 2022:


			Square	Purchase
	Properties	Beds	Footage	Price
SNF	15	1,354	406,135	$	181,795,000
AL or AL/MC	3	221	136,765		25,525,000
Total Real Estate Properties	18	1,575	542,900	$	207,320,000


					2022
					Lease
Property	Location	Date Purchased	Type	Beds	Revenue ⁽¹⁾
Sheridan Care Center	Sheridan, OR	August 3, 2012	SNF	51	$	246,000
Fernhill Care Center	Portland, OR	August 3, 2012	SNF	63		262,000
Friendship Haven Healthcare and Rehabilitation Center	Galveston County TX	September 14, 2012	SNF	150		706,000
Pacific Health and Rehabilitation Center	Tigard, OR	December 24, 2012	SNF	73		484,000
Brookstone of Aledo	Aledo, IL	July 2, 2013	AL	66		382,000
Sundial Assisted Living ⁽²⁾	Redding, CA	December 18, 2013	AL	65		—
Pennington Gardens ⁽²⁾	Chandler, AZ	July 17, 2017	AL/MC	90		—
Yucaipa Hill Post Acute	Yucaipa, CA	July 2, 2021	SNF	82		532,000
Creekside Post Acute	Yucaipa, CA	July 2, 2021	SNF	59		238,000
University Post Acute	Mentone, CA	July 2, 2021	SNF	50		227,000
Calhoun Health Center	Calhoun, GA	December 30, 2021	SNF	100		239,000
Maple Ridge Health Care Center	Cartersville, GA	December 30, 2021	SNF	74		947,000
Chatsworth Health Care Center	Chatsworth, GA	December 30, 2021	SNF	120		1,729,000
East Lake Arbor	Decatur, GA	December 30, 2021	SNF	103		451,000
Fairburn Health Care Center	Fairburn, GA	December 30, 2021	SNF	120		724,000
Grandview Health Care Center	Jasper, GA	December 30, 2021	SNF	60		532,000
Rosemont at Stone Mountain	Stone Mountain, GA	December 30, 2021	SNF	149		1,367,000
Willowwood Nursing Center & Rehab	Flowery Branch, GA	December 30, 2021	SNF	100		515,000
Total				1,575

(1)

Represents year-to-date rental revenue based on in-place leases, including straight-line rent, through June 30, 2022 and excluding $1.2 million in tenant reimbursement revenue, $0.03 million in above-market lease amortization and $0.3 million in revenue related to the settlements for the termination of the Pennington Gardens and Sundial Assisted Living leases.

(2)	See Note 3 to the accompanying Notes to Condensed Consolidated Financial Statements for further information on these two properties. Rents due under the Pennington Gardens Operations and Sundial Operations leases are eliminated in consolidation.

Table of Contents

Summit Equity-Method Investment Portfolio Properties

We continue to believe that raising institutional joint venture equity to make acquisitions will be accretive to shareholder value. Our primary source of equity since 2015 has been institutional funds raised through a joint venture structure and accounted for as equity-method investments. We still believe this is a prudent strategy for growth; however, in the future, we may raise additional equity capital through alternative methods if warranted by market conditions.

A summary of the condensed combined financial data for the balance sheets and statements of income for all unconsolidated Equity-Method Investments are as follows (see below under Indiana JV for information regarding the sale of our equity interest in the Indiana JV on June 11, 2021 and see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements; accordingly, the financial information for the Indiana JV is not included in the June 30, 2022 or December 31, 2021 condensed combined balance sheet and for the three and six months ended June 30, 2021 condensed combined statement of income below):


	June 30,		December 31,
Condensed Combined Balance Sheets:	2022		2021
Total Assets	$	267,193,000	$	286,572,000
Total Liabilities	$	190,974,000	$	213,812,000
Members Equity:
Summit	$	7,703,000	$	8,017,000
JV Partners	$	68,516,000	$	64,743,000
Total Members Equity	$	76,219,000	$	72,760,000


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Combined Statements of Operations:	2022		2021		2022		2021
Total Revenue	$	9,536,000	$	9,913,000	$	19,136,000	$	19,885,000
(Loss) income from Operations	$	(93,000)	$	3,793,000	$	4,558,000	$	7,354,000
Net (loss) income	$	(2,062,000)	$	1,507,000	$	1,409,000	$	3,583,000

Summit equity interest in Equity-Method Investments net (loss) income	$	(1,066,000)	$	196,000	$	(424,000)	$	501,000
JV Partners interest in Equity-Method Investments net (loss) income	$	(996,000)	$	1,311,000	$	1,832,000	$	3,083,000

Summit Union Life Holdings, LLC

In April 2015, through our operating partnership (“Operating Partnership”), we formed Summit Union Life Holdings, LLC (“SUL JV”) with Best Years, LLC (“Best Years”), an unrelated entity and a U.S.-based affiliate of Union Life Insurance Co, Ltd. (a Chinese corporation), and entered into a limited liability company with Best Years with respect to the SUL JV (the “SUL LLC Agreement”). The SUL JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements.

The following reconciles our 10% equity investment in the SUL JV from inception through June 30, 2022:


JV 2 Properties (Colorado, Oregon and Virginia) – April 2015	$	1,100,000
Creative Properties (Texas) – October 2015		837,000
Cottage Properties (Wisconsin) – December 2015		1,811,000
Riverglen (New Hampshire) – April 2016		424,000
Delaware Properties – September 2016		1,846,000
Total investments		6,018,000
Income from equity-method investee		1,634,000
Distributions		(4,370,000)
Total investment at June 30, 2022	$	3,282,000

Table of Contents

A summary of the condensed consolidated financial data for the balance sheets and statements of income for the unconsolidated SUL JV, of which we own a 10% equity interest, is as follows:


	June 30,			December 31,
Condensed Consolidated Balance Sheets of SUL JV:	2022			2021
Real estate properties and intangibles, net	$	123,237,000		$	125,183,000
Cash and cash equivalents		4,595,000			4,929,000
Other assets		13,001,000			14,322,000
Total Assets:	$	140,833,000		$	144,434,000

Loans payable, net	$	90,692,000	⁽¹⁾	$	98,432,000
Other liabilities		8,240,000			8,463,000
Members’ equity:
Best Years		38,504,000			34,568,000
Summit		3,397,000			2,971,000
Total Liabilities and Members’ Equity	$	140,833,000		$	144,434,000

(1)

In June 2022, the $6.8 million loan payable related to the Cottage Properties was paid off using funds received from the members’ (Summit’s portion was approximately $650,000).


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Consolidated Statements of Income of SUL JV:	2022		2021		2022		2021
Total revenue	$	5,240,000	$	5,091,000	$	10,435,000	$	10,267,000
Property operating expenses		(2,644,000)		(1,902,000)		(5,120,000)		(4,157,000)
Net operating income		2,596,000		3,189,000		5,315,000		6,110,000
General and administrative expense		(104,000)		(108,000)		(205,000)		(208,000)
Depreciation and amortization expense		(1,023,000)		(1,271,000)		(2,043,000)		(2,545,000)
Income from operations		1,469,000		1,810,000		3,067,000		3,357,000
Interest expense		(1,075,000)		(1,155,000)		(2,179,000)		(2,314,000)
Amortization of debt issuance costs		(216,000)		(51,000)		(265,000)		(104,000)
Other income (expense)		1,000		5,000		3,000		(152,000)
Net income	$	179,000	$	609,000	$	626,000	$	787,000

Summit equity interest in SUL JV net income	$	18,000	$	61,000	$	63,000	$	79,000

Table of Contents

As of June 30, 2022, the 17 properties held by SUL JV, our unconsolidated 10% equity-method investment, of which 11 are 100% leased on a triple net basis and six are operated directly, are as follows:


			Number of
Property	Location	Type	Beds
Lamar Estates	Lamar, CO	SNF	60
Monte Vista Estates	Monte Vista, CO	SNF	60
Myrtle Point Care Center	Myrtle Point, OR	SNF	55
Gateway Care and Retirement Center	Portland, OR	SNF/IL	91
Applewood Retirement Community	Salem, OR	IL	69
Shenandoah Senior Living	Front Royal, VA	AL	78
Pine Tree Lodge Nursing Center	Longview, TX	SNF	92
Granbury Care Center	Granbury, TX	SNF	181
Twin Oaks Nursing Center	Jacksonville, TX	SNF	116
Dogwood Trails Manor	Woodville, TX	SNF	90
Carolina Manor	Appleton, WI	AL	45
Carrington Manor	Green Bay, WI	AL	20
Marla Vista Manor	Green Bay, WI	AL	40
Marla Vista Gardens	Green Bay, WI	AL	20
Riverglen House of Littleton	Littleton, NH	AL	59
Atlantic Shore Rehabilitation and Health Center	Millsboro, DE	SNF	181
Pinnacle Rehabilitation and Health Center	Smyrna, DE	SNF	151
Total:			1,408

Equity-Method Partner – Fantasia Investment III LLC

In 2016 and 2017, through our Operating Partnership, we entered into three separate limited liability company agreements (collectively, the “Fantasia Agreements”) with Fantasia Investment III LLC (“Fantasia”), an unrelated entity and a U.S.-based affiliate of Fantasia Holdings Group Co., Limited (a Chinese corporation listed on the Stock Exchange of Hong Kong (HKEX)), and formed three separate companies, Summit Fantasia Holdings, LLC (“Fantasia I”), Summit Fantasia Holdings II, LLC (“Fantasia II”) and Summit Fantasia Holdings III, LLC (“Fantasia III”) (collectively, the “Fantasia JVs”). The Fantasia JVs are not consolidated in our condensed consolidated financial statements and are accounted for under the equity-method in our condensed consolidated financial statements. Through the Fantasia JVs: we own a 35% interest in one senior housing facility located in California (in March 2022, we sold one facility located in Oregon); a 20% interest in two skilled nursing facilities located in Rhode Island; and a 10% interest in nine skilled nursing facilities located in Connecticut.

The following reconciles our equity investments in the Fantasia JVs from inception through June 30, 2022:


Summit Fantasia Holdings, LLC – October 2016	$	2,593,000
Summit Fantasia Holdings II, LLC – February 2017		1,923,000
Summit Fantasia Holdings III, LLC – August 2017		1,954,000
Total investment		6,470,000
Income from Fantasia JVs		813,000
Distributions		(3,396,000)
Total Fantasia investments at June 30, 2022	$	3,887,000

Table of Contents

A summary of the condensed combined financial data for the balance sheets and statements of income for the unconsolidated Fantasia JVs, of which we own a 10% to 35% equity interest, is as follows:


	June 30,		December 31,
Condensed Combined Balance Sheets of Fantasia JVs:	2022		2021
Real estate properties, net⁽²⁾	$	84,443,000	$	88,908,000
Cash and cash equivalents		6,050,000		8,135,000
Assets held for sale ⁽¹⁾		—		10,454,000
Other assets		7,648,000		6,834,000
Total Assets:	$	98,141,000	$	114,331,000

Loans payable, net	$	62,107,000	$	67,154,000
Liabilities held for sale ⁽¹⁾		—		7,537,000
Other liabilities		7,322,000		8,885,000
Members’ equity:
Fantasia JVs		24,760,000		25,967,000
Summit		3,952,000		4,788,000
Total Liabilities and Members’ Equity	$	98,141,000	$	114,331,000

(1)

In May 2021, the Fantasia I JV entered into an agreement to sell one of the properties in the Summit Fantasia Holdings, LLC equity-method investment; therefore, such property was accounted for as Held for Sale as of December 31, 2021. In March 2022, the property was sold for $11.0 million and Fantasia I recorded a gain of $1.2 million.

(2)	In June 2022, Fantasia I recorded an impairment of approximately $3.2 million related to the Sun Oak Assisted Living property.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Combined Statements of Operations of Fantasia JVs:	2022		2021		2022		2021
Total revenue	$	3,398,000	$	3,929,000	$	6,905,000	$	7,835,000
Property operating expenses		(1,397,000)		(1,518,000)		(2,763,000)		(2,994,000)
Net operating income		2,001,000		2,411,000		4,142,000		4,841,000
General and administrative expense		(127,000)		(138,000)		(256,000)		(248,000)
Depreciation and amortization expense		(607,000)		(702,000)		(1,233,000)		(1,429,000)
Impairment on real estate property		(3,242,000)		—		(3,242,000)		—
Gain on sale of real estate		—		—		1,247,000		—
(Loss) income from operations		(1,975,000)		1,571,000		658,000		3,164,000
Interest expense		(769,000)		(893,000)		(1,569,000)		(1,786,000)
Amortization of debt issuance costs		(39,000)		(16,000)		(62,000)		(32,000)
Other income		12,000		155,000		15,000		522,000
Net (loss) income	$	(2,771,000)	$	817,000	$	(958,000)	$	1,868,000

Summit equity interest in Fantasia JVs net (loss) income	$	(1,137,000)	$	127,000	$	(661,000)	$	329,000

Table of Contents

As of June 30, 2022, the 12 properties in Fantasia JVs, our unconsolidated equity-method investments, are all 100% leased on a triple net basis, and are as follows:


			Number of
Property	Location	Type	Beds
Sun Oak Assisted Living	Citrus Heights, CA	AL/MC	78
Trinity Health and Rehabilitation Center	Woonsocket, Rhode Island	SNF	185
Hebert Nursing Home	Smithfield, Rhode Island	SNF	133
Chelsea Place Care Center	Hartford, CT	SNF	234
Touchpoints at Manchester	Manchester, CT	SNF	131
Touchpoints at Farmington	Farmington, CT	SNF	105
Fresh River Healthcare	East Windsor, CT	SNF	140
Trinity Hill Care Center	Trinity Hill, CT	SNF	144
Touchpoints at Bloomfield	Bloomfield, CT	SNF	150
Westside Care Center	Westside, CT	SNF	162
Silver Springs Care Center	Meriden, CT	SNF	159
Touchpoints of Chestnut	Chestnut, CT	SNF	60
Total:			1,681

Summit Fantasy Pearl Holdings, LLC

In October 2017, through our Operating Partnership, we entered into a limited liability company agreement (the “FPH LLC Agreement”) with Fantasia, Atlantis Senior Living 9, LLC, a Delaware limited liability company (“Atlantis”), and Fantasy Pearl LLC, a Delaware limited liability company (“Fantasy”), and formed Summit Fantasy Pearl Holdings, LLC (the “FPH JV”). The FPH JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements.

The following reconciles our equity investment in the FPH JV from inception through June 30, 2022:


Iowa properties – November 2017	$	929,000
Total investment		929,000
Income from equity-method investee		228,000
Distributions		(803,000)
Total FPH investment at June 30, 2022	$	354,000

Table of Contents

A summary of the condensed consolidated financial data for the balance sheets and statements of operations for the unconsolidated FPH JV is as follows:


Condensed Consolidated Balance Sheets of FPH JV:	June 30, 2022		December 31, 2021
Real estate properties, net	$	24,226,000	$	24,840,000
Cash and cash equivalents		1,944,000		1,650,000
Other assets		2,049,000		1,317,000
Total Assets:	$	28,219,000	$	27,807,000

Loans payable, net	$	20,536,000	$	20,764,000
Other liabilities		2,077,000		2,577,000
Members’ equity:
Fantasia JVs		5,252,000		4,207,000
Summit		354,000		259,000
Total Liabilities and Members’ Equity	$	28,219,000	$	27,807,000


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Consolidated Statements of Income of FPH JV:	2022		2021		2022		2021
Total revenue	$	898,000	$	893,000	$	1,796,000	$	1,783,000
Property operating expenses		(142,000)		(138,000)		(276,000)		(263,000)
Net operating income		756,000		755,000		1,520,000		1,520,000
General and administrative expense		(36,000)		(36,000)		(73,000)		(73,000)
Depreciation and amortization expense		(307,000)		(307,000)		(614,000)		(614,000)
Income from operations		413,000		412,000		833,000		833,000
Interest expense		(247,000)		(252,000)		(490,000)		(503,000)
Amortization of debt issuance costs		(16,000)		(16,000)		(31,000)		(31,000)
Other income (expense)		380,000		(63,000)		1,429,000		629,000
Net income	$	530,000	$	81,000	$	1,741,000	$	928,000

Summit equity interest in FPH JV net income	$	53,000	$	8,000	$	174,000	$	93,000

As of June 30, 2022, the six properties of our unconsolidated equity-method investments in FPH JV, all of which are 100% leased on a triple net basis, are as follows:


			Number of
Property	Location	Type	Beds
Accura Healthcare of Bancroft	Bancroft, Iowa	SNF/AL	46
Accura Healthcare of Milford	Milford, Iowa	SNF/AL	94
Accura Healthcare of Carroll	Carroll, Iowa	SNF/IL	98
Accura Healthcare of Cresco	Cresco, Iowa	SNF	46
Accura Healthcare of Marshalltown	Marshalltown, Iowa	SNF	84
Accura Healthcare of Spirit Lake	Spirit Lake, Iowa	SNF	85
Total:			453

Indiana JV

In June 2021, we sold our 15% interest in the Indiana JV for approximately $5.4 million. The Indiana JV was not consolidated in our consolidated financial statements and was accounted for under the equity-method.

Table of Contents

The following reconciles our equity investment in the Indiana JV from inception through June 11, 2021:


Indiana properties – March 2019	$	4,906,000
Total investment		4,906,000
Loss from equity-method investee		(1,433,000)
Distributions		(1,577,000)
Total Indiana JV investment at June 11, 2021		1,896,000
Funds received from sale of interest in equity-method investment		5,411,000
Total gain on sale of Indiana JV equity-method investment at June 11, 2021	$	3,515,000

Distributions from Equity-Method Investments

For the six months ended June 30, 2022 and 2021, we recorded distributions and cash received for distributions from our Equity-Method Investments as follows:


	Six Months Ended June 30,
	2022		2021
Distributions	$	610,000	$	997,000

Cash received for distributions	$	546,000	$	1,605,000

Asset Management Fees

We serve as the manager or operating member (collectively, the manager) of our Equity-Method Investments and provide management services in exchange for fees and reimbursements. As the manager, we are paid an annual asset management fee for managing the properties owned by our Equity-Method Investments, as defined in the agreements. For the three months ended June 30, 2022 and 2021, we recorded approximately $0.2 million and $0.3 million, respectively, in asset management fees from our Equity-Method Investments. For the six months ended June 30, 2022 and 2021, we recorded approximately $0.3 million and $0.6 million, respectively, in asset management fees from our Equity-Method Investments.

Critical Accounting Policies

There have been no material changes to our critical accounting policies as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the SEC on March 31, 2022 except for the additional revenue recognition – resident fees and services policy included in Note 2 to the accompanying Notes to Condensed Consolidated Financial Statements.

Results of Operations

Our results of operations are described below:

Table of Contents

Three Months Ended June 30, 2022 Compared to Three Months Ended June 30, 2021


	Three Months Ended
	June 30,
	2022		2021		$ Change
Total rental revenues	$	5,435,000	$	1,284,000	$	4,151,000
Resident fees and services income		863,000		—		863,000
Property operating and resident costs		(1,584,000)		(210,000)		(1,374,000)
Net operating income ⁽¹⁾		4,714,000		1,074,000		3,640,000
Asset management fees		165,000		295,000		(130,000)
Interest income from notes receivable		—		4,000		(4,000)
General and administrative		(1,132,000)		(862,000)		(270,000)
Depreciation and amortization		(1,848,000)		(393,000)		(1,455,000)
Income (loss) from equity-method investees		(1,131,000)		(550,000)		(581,000)
Gain on sale of equity-method investment		—		3,515,000		(3,515,000)
Other income		161,000		6,000		155,000
Interest expense		(3,105,000)		(516,000)		(2,589,000)
Net (loss) income		(2,176,000)		2,573,000		(4,749,000)
Noncontrolling interests’ share in (income)		(18,000)		(22,000)		4,000
Net (loss) income applicable to common stockholders	$	(2,194,000)	$	2,551,000	$	(4,745,000)

(1)

Net operating income (“NOI”) is a non-GAAP supplemental measure used to evaluate the operating performance of real estate properties. We define NOI as total rental revenues, resident fees and service income less property operating and resident costs. NOI excludes asset management fees, interest income from notes receivable, general and administrative expense, depreciation and amortization, income from equity-method investees, other income, and interest expense. We believe NOI provides investors relevant and useful information because it measures the operating performance of the REIT’s real estate at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess and compare property-level performance. We believe that net income (loss) is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect the aforementioned excluded items. Additionally, NOI as we define it may not be comparable to NOI as defined by other REITs or companies, as they may use different methodologies for calculating NOI.

Total rental revenues for our properties includes rental revenues and tenant reimbursements for property taxes and insurance. Resident fees and services income are generated from Pennington Gardens Operations (effective February 2022) and Sundial Operations (effective June 2022) (collectively “Operated Properties”). Property operating and resident costs include insurance, property taxes, resident costs related to the Operated Properties of $0.8 million and other operating expenses. Net operating income increased approximately $3.6 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 primarily due to rental revenues generated from the CA3 and GA8 acquisitions in July and December 2021, respectively.

Asset management fees decreased approximately $0.1 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 due to the sale of the Indiana JV in June 2021 (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements).

The net increase in general and administrative expenses of $0.3 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 is primarily due to an increase in legal and accounting fees of $0.2 million.

The net increase in depreciation and amortization of $1.5 million and interest expense of $2.6 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 is primarily due to CA3 and GA8 acquisitions in July and December 2021.

The net increase in loss of approximately $0.6 million from our equity-method investments for the three months ended June 30, 2022 is mainly due to the impairment loss of $1.2 million related to the Fantasia I JV and the net loss for three months ended June 30, 2021 related to the Indiana JV of $0.7 million due to the sale of our interest in June 2021.

Table of Contents

Six Months Ended June 30, 2022 Compared to Six Months Ended June 30, 2021


	Six Months Ended
	June 30,
	2022		2021		$ Change
Total rental revenues	$	10,976,000	$	2,208,000	$	8,768,000
Resident fees and services income		1,271,000		—		1,271,000
Property operating and resident costs		(2,732,000)		(430,000)		(2,302,000)
Net operating income ⁽¹⁾		9,515,000		1,778,000		7,737,000
Asset management fees		330,000		624,000		(294,000)
Interest income from notes receivable		—		13,000		(13,000)
General and administrative		(2,180,000)		(2,493,000)		313,000
Depreciation and amortization		(3,685,000)		(792,000)		(2,893,000)
Loss from equity-method investees		(489,000)		(785,000)		296,000
Gain on sale of equity-method investment		—		3,515,000		(3,515,000)
Other income		163,000		11,000		152,000
Interest expense		(6,136,000)		(1,038,000)		(5,098,000)
Net (loss) income		(2,482,000)		833,000		(3,315,000)
Noncontrolling interests’ share in (income)		(37,000)		(40,000)		3,000
Net (loss) income applicable to common stockholders	$	(2,519,000)	$	793,000	$	(3,312,000)

Total rental revenues for our properties includes rental revenues and tenant reimbursements for property taxes and insurance. Resident fees and services income are generated from the Operated Properties. Property operating and resident costs include insurance, property taxes, resident costs related to the Operated Properties of $1.2 million and other operating expenses. Net operating income increased approximately $7.7 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 primarily due to rental revenues generated from the CA3 and GA8 acquisitions in July and December 2021, respectively.

Asset management fees decreased approximately $0.3 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 due to the sale of the Indiana JV in June 2021 (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements).

The net decrease in general and administrative expenses of $0.3 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 is primarily due to the write off of expenses associated with a terminated transaction of approximately $0.6 million in March 2021 offset by an increase in legal and accounting fees of $0.3 million.

The net increase in depreciation and amortization of $2.9 million and interest expense of $5.0 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 is primarily due to CA3 and GA8 acquisitions in July and December 2021.

The net decrease of approximately $0.3 million in loss from our equity-method investments for the six months ended June 30, 2022 is primarily due to the impairment loss of $1.2 million related to the Fantasia I JV offset by the sale of the property in the Fantasia I JV (resulting in loss from the Fantasia I JV of approximately $0.9 million for the six months ended June 30, 2022 versus income for the six months ended June 30, 2021 of $0.1 million), offset by the net loss for six months ended June 30, 2021 related to the Indiana JV of $1.3 million versus no loss for the six months ended June 30, 2022 due to the sale of our interest in the Indiana JV in June 2021.

The net decrease in gain on sale of equity-method investment of approximately $3.5 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 is due to the sale of our equity interest in the Indiana JV (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements for further information related to the sale of our interest in the Indiana JV in June 2021).

Liquidity and Capital Resources

As of June 30, 2022, we had approximately $13.1 million in cash and cash equivalents on hand. Based on current conditions, we believe that we have sufficient capital resources to sustain operations.

Going forward, we expect our primary sources of cash to be rental revenues, joint venture distributions, and asset management fees. In addition, we may increase cash through the sale of additional properties, which may result in the deconsolidation of properties we already own, or borrowing against currently-owned properties. For the foreseeable future, we expect our primary uses of cash to be for

Table of Contents

funding future acquisitions, investments in joint ventures, operating expenses, interest expense on outstanding indebtedness and the repayment of principal on loans payable. We may also incur expenditures for renovations of our existing properties, making our facilities more appealing in their market.

Seven of our debt obligations are long-term, fixed rate U.S. Department of Housing and Urban Development (“HUD”)-insured loans that mature between 2039 and 2055. The other debt obligations are short-term loans that mature in July 2024 through December 2026 with variable interest rates starting at approximately 4% through 12% and based on the Secured Overnight Financing Rate (“SOFR”) or the bank’s base rate as documented in all of our loan agreements. We expect to refinance these short-term loans with long-term, fixed rate HUD-insured debt.

Our liquidity will increase if cash from operations exceeds expenses, we receive net proceeds from the sale of whole or partial interest in a property or properties, or refinancing results in excess loan proceeds. Our liquidity will decrease as proceeds are expended in connection with our acquisitions and operation of properties.

Credit Facilities and Loan Agreements

As of June 30, 2022, we had debt obligations of approximately $184.3 million. The outstanding balance by lender is as follows (see Note 4 to the accompanying Notes to Condensed Consolidated Financial Statements for further information regarding our refinancing arrangements):

●

Capital One Multifamily Finance, LLC (HUD-insured) – approximately $10.1 million maturing September 2053

●

Lument Capital (formerly ORIX Real Estate Capital, LLC) (HUD-insured) – approximately $35.4 million maturing from September 2039 through April 2055

●

CIBC Bank, USA - approximately $106.0 million maturing from July 2024 to December 2024

●

Oxford Finance LLC – approximately $32.8 million maturing from March 2025 to December 2026

Distributions

We made no stockholder distributions during the three months ended June 30, 2022.

Funds from Operations (“FFO”)

FFO is a non-GAAP supplemental financial measure that is widely recognized as a measure of REIT operating performance. We compute FFO in accordance with the definition outlined by the National Association of Real Estate Investment Trusts (“NAREIT”). NAREIT defines FFO as net income (loss), computed in accordance with GAAP, excluding gains or losses from sales of property, plus depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

Table of Contents

Our FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that interpret the current NAREIT definition differently than we do. We believe that FFO is helpful to investors and our management as a measure of operating performance because it excludes depreciation and amortization, gains and losses from property dispositions, impairments and extraordinary items, and as a result, when compared period to period, reflects the impact on operations from trends in occupancy rates, rental rates, operating costs, development activities, general and administrative expenses, and interest costs, which is not immediately apparent from net income. Historical cost accounting for real estate assets in accordance with GAAP implicitly assumes that the value of real estate diminishes predictably over time. Since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered the presentation of operating results for real estate companies that use historical cost accounting alone to be insufficient. As a result, our management believes that the use of FFO, together with the required GAAP presentations, provide a more complete understanding of our performance. Factors that impact FFO include start-up costs, fixed costs, delays in buying assets, lower yields on cash held in accounts pending investment, income from portfolio properties and other portfolio assets, interest rates on acquisition financing and operating expenses. FFO should not be considered as an alternative to net income (loss), as an indication of our performance, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

The following is the reconciliation from net income (loss) applicable to common stockholders, the most direct comparable financial measure calculated and presented with GAAP, to FFO for the three and six months ended June 30, 2022 and 2021:


	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2022		2021			2022		2021
Net (loss) income applicable to common stockholders (GAAP)	$	(2,194,000)	$	2,551,000		$	(2,519,000)	$	793,000
Adjustments:
Depreciation and amortization		1,843,000		393,000			3,674,000		792,000
Depreciation and amortization related to non-controlling interests		(11,000)		(9,000)			(22,000)		(19,000)
Depreciation related to Equity-Method Investments		226,000		388,000	⁽¹⁾		456,000		815,000	⁽²⁾
Impairment on real estate property in Fantasia I (included in loss from Equity-Method Investments)		1,200,000		—			1,200,000		—
Gain on sale of property in Fantasia I (included in income from Equity-Method Investments)		—		—			(437,000)		—
Gain on sale of equity-method investment		—		(3,515,000)			—		(3,515,000)
Funds provided by (used in) operations (FFO) applicable to common stockholders	$	1,064,000	$	(192,000)	⁽¹⁾		2,352,000	$	(1,134,000)	⁽²⁾
Weighted-average number of common shares outstanding - basic		23,027,978		23,027,978			23,027,978		23,027,978
FFO per weighted average common shares - basic	$	0.05	$	(0.01)		$	0.10	$	(0.05)
Weighted-average number of common shares outstanding - diluted		23,027,978		23,553,606			23,027,978		23,553,606
FFO per weighted average common shares - diluted	$	0.05	$	(0.01)		$	0.10	$	(0.05)

(1)

Revised to exclude $0.1 million above-market lease amortization.

(2)

Revised to exclude $0.2 million above-market lease amortization.

Subsequent Events

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable.

Table of Contents

Item 4. Controls and Procedures.

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our senior management, including our Chief Executive Officer (Principal Executive Officer) and our Chief Financial Officer (Principal Financial Officer), to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) evaluated the effectiveness of our disclosure controls and procedures and concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

There have been no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.Legal Proceedings.

See Note 12 to the accompanying Notes to Condensed Consolidated Financial Statements for a summary of our material legal proceedings.

Item 1A.Risk Factors.

There have been no material changes to the Risk Factors described in Part I, Item 1A, Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, 2021, as updated by Part II, Item 1A, Risk Factors in our quarterly report on Form 10-Q for the quarter ended March 31, 2022.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

(a)	We did not sell any equity securities that were not registered under the Securities Act of 1933, as amended, during the periods covered by this Form 10-Q.

(b)	Not applicable.

(c)	During the six months ended June 30, 2022, we redeemed no shares pursuant to our stock repurchase program.

Item 3.Defaults Upon Senior Securities.

None.

Item 4.Mine Safety Disclosures.

None.

Item 5.Other Information.

None.

Table of Contents

Item 6.Exhibits.


Ex.		Description
3.1		Amendment and Restatement of Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K filed on March 24, 2006).

3.2		Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.3 to Post-Effective Amendment No. 1 to the Registration Statement on Form S-11 (No. 333-121238) filed on December 23, 2005).

3.3		Articles of Amendment of the Company dated October 16, 2013 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 22, 2013).

3.4		Second Articles of Amendment and Restatement of Articles of Incorporation of the Company dated June 30, 2010 (incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K filed on March 20, 2015).

4.1		Subscription Agreement (incorporated by reference to Appendix A to the prospectus included on Post-Effective Amendment No. 2 to the Registration Statement on Form S-11 (No. 333-155640) filed on April 16, 2010 (“Post-Effective Amendment No. 2”)).

4.2		Statement regarding restrictions on transferability of shares of common stock (to appear on stock certificate or to be sent upon request and without charge to stockholders issued shares without certificates) (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-11 (No. 333-121238) filed on December 14, 2004).

4.3		Amended and Restated Distribution Reinvestment Plan (incorporated by reference to Appendix B to the prospectus dated April 16, 2010 included on Post-Effective Amendment No. 2).

4.4		2015 Omnibus Incentive Plan dated October 28, 2015 (incorporated by reference to Appendix A to the Definitive Proxy Statement on Schedule 14A filed on September 28, 2015).

10.1		Temporary Space License Agreement between Lakehills CM-CG LLC, a Delaware limited liability company, as licensor, and Summit Healthcare REIT, Inc., as licensee, dated April 1, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2022).

10.2		Standard Office lease between Lakehills CM-CG LLC, a Delaware limited liability company, as landlord, and Summit Healthcare REIT, Inc., as tenant, dated April 1, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2022).

31.1		Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002.

101.1		The following information from the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2022, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Cash Flows.

104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SUMMIT HEALTHCARE REIT, INC.

	/s/ Kent Eikanas
Date: August 12, 2022	Kent Eikanas
	Chief Executive Officer
	(Principal Executive Officer)

	/s/ Elizabeth A. Pagliarini
Date: August 12, 2022	Elizabeth A. Pagliarini
	Chief Financial Officer
	(Principal Financial Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

Summit Healthcare REIT 10-Q2022 Q2 Quarterly report

Content analysis